FDA Inspection
Taro Pharmaceuticals Inc.Taro Pharmaceuticals Inc. – FDA Inspection, May 3, 2019
Record Details
This FDA Inspection record concerns Taro Pharmaceuticals Inc., with an inspection on May 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6c8456ba-f9bc-45c1-aab9-d88bf456c31a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1088553
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.194(a)(1)Description and Identification of Samples
- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Taro Pharmaceuticals Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| September 16, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| July 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taro Pharmaceuticals Inc.
- FDA Inspection 1312804 - 2026-03-27
- FDA Inspection 1257703 - 2024-09-20
- FDA Inspection 1180887 - 2022-09-16
- FDA Inspection 1001628 - 2017-01-20
- FDA Inspection 984831 - 2016-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.